Pharmaceutical tablet
Latest Merck & Co., Inc. Patents:
- Assays for resistance to echinocandin-class drugs
- ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS
- Assays for resistance to echinocandin-class drugs
- INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Description
FIG. 1 is a perspective view of a pharmaceutical tablet showing our new design;
FIG. 2 is a top plan view thereof, the bottom plan view being identical;
FIG. 3 is a side view thereof, the opposite side being identical; and,
FIG. 4 is an end view thereof, the opposite end being identical.
Referenced Cited
U.S. Patent Documents
Other references
| 55542 | June 1920 | Wipf |
| D201228 | May 1965 | Horne |
| D210709 | April 1968 | Douglas |
| D231406 | April 1974 | Biallo |
| D286919 | November 25, 1986 | Flockhart et al. |
| D293487 | December 29, 1987 | Swanson |
- Physicians' Desk Reference items Vaseretic.RTM. (Merck Sharp & Dohme) p. 419, Wyeth-Ayerst Inderal.RTM. p. 436, 1990, 44th Ed.
Patent History
Patent number: D346442
Type: Grant
Filed: Sep 29, 1992
Date of Patent: Apr 26, 1994
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katadare (Norristown, PA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorneys: Hesna J. Pfeiffer, Joseph F. DiPrima
Application Number: 7/953,579
Type: Grant
Filed: Sep 29, 1992
Date of Patent: Apr 26, 1994
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katadare (Norristown, PA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: M. H. Tung
Attorneys: Hesna J. Pfeiffer, Joseph F. DiPrima
Application Number: 7/953,579
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)
